Protection and in Vivo Selection of Hematopoietic Stem Cells Using Temozolomide, O6-Benzylguanine, and an Alkyltransferase-Expressing Retroviral Vector
Open Access
- 31 January 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (1) , 78-87
- https://doi.org/10.1006/mthe.2000.0223
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Characterization of the P140K, PVP(138-140)MLK, and G156A O6-Methylguanine-DNA Methyltransferase Mutants: Implications for Drug Resistance Gene TherapyHuman Gene Therapy, 1999
- Retroviral Marking and Transplantation of Rhesus Hematopoietic Cells by Nonmyeloablative ConditioningHuman Gene Therapy, 1999
- Dominant Selection of Hematopoietic Progenitor Cells with Retroviral MDR1 Co-Expression VectorsHuman Gene Therapy, 1998
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumours: possible significance in nitrosourea therapyCarcinogenesis: Integrative Cancer Research, 1996
- The Prevention of Thymic Lymphomas in Transgenic Mice by Human O 6 -Alkylguanine-DNA AlkyltransferaseScience, 1993
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- O6-Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenograftsJournal of Neurosurgery, 1989
- Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.The Journal of Experimental Medicine, 1987
- DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cellsNature, 1980